Further Characterization of the Expression in Liver and Catalytic Activity of CYP2B6

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 3, 1998, Pages 1253-1259

  Ekins, Sean ^a   Vandenbranden, Mark ^a   Ring, Barbara J ^a   Gillespie, Jennifer S ^a   Yang, Tian J ^a   Gelboin, Harry V ^a   Wrighton, Steven A ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; MIDAZOLAM; MONOCLONAL ANTIBODY; N DEMETHYLASE; S MEPHENYTOIN N DEMETHYLASE; S-MEPHENYTOIN N-DEMETHYLASE; UNSPECIFIC MONOOXYGENASE; BENZPHETAMINE; NORMEPHENYTOIN; TESTOSTERONE;

ARTICLE; BINDING SITE; ENZYMOLOGY; GENETICS; HUMAN; HYDROXYLATION; IMMUNOLOGY; LIVER; METABOLISM; DEMETHYLATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME CONFORMATION; ENZYME KINETICS; ENZYME MECHANISM; ENZYME METABOLISM; ENZYME SPECIFICITY; ENZYME SUBSTRATE; HUMAN CELL; LIVER MICROSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIBODIES, MONOCLONAL; ARYL HYDROCARBON HYDROXYLASES; BINDING SITES; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; HYDROXYLATION; LIVER; MIDAZOLAM; OXIDOREDUCTASES, N-DEMETHYLATING;

EID: 0032160463     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Baker MT, Oison MJ, Wang Y, Ronnenberg WC, Johnson JT and Brady AN (191)5) Isoflurane-chlorodifluoroethane interaction in human liver microsomes. Drug Metab Dispos 23:60-64.
2. Blanck J, Rein H, Sommer M, Ristau O, Smettan G and Ruckpaul K (1983) Correlations between spin equilibrium shift, reduction rate, and JV-demethylation activity in liver microsomal cytochrome P-450 and a series of benzphetamine analogues as substrates. Biochem Pharmacol 32:1683-1688.
3. Boxenbaum HG, Riegelman S and Elashoff RM (1974) Statistical estimations in pharmacokinetics. J Pharmacokinet Biopharm 2:123-148.
4. Code EL, Crespi CL, Penman BW, Gonzalez FJ, Chang TKH and Waxman DJ (1995) Immunochemical and enzymatic characterization of human hepatic levels of CYP2B6. ISSXProc 8:100.
5. Code EL, Crespi CL, Penman BW, Gonzalez FJ, Chang TKH and Waxman DJ (1997) Interindividual hepatic expression, substrate specificity, and role in procarcinogen activation. Drug Metab Dispos 25:985-992.
6. Czerwinski M, McLemore TL, Gelboin HV and Gonzalez FJ (1994) Quantification of CYP2B7, CYP4B1 and CYPOR messenger RNAs in normal human lung and lung tumors. Cancer Res 54:1085-1091.
7. Ekins S, VandenBranden M, Ring BJ and Wrighton SA (1997) Examination of purported probes of human CYP2B6. Pharmacogenetics 7:165-179.
8. Fukuda K, Ohta T, Oshima Y, Ohashi N, Yoshikawa M and Yamazoe Y (1997) Specific CYP3A4 inhibitors in grapefruit juice: Furocoumarin dimers as components of drug interactions. Pharmacogenetics 7:391-396.
9. Ghosal A, Satoh H, Thomas PE, Bush E and Moore D (1996) Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cDNAexpressed human cytochrome P450. Drug Metab Dispos 24:940-947.
10. Gorski JC, Hall SD, Jones DR, VandenBranden M and Wrighton SA (1994) Regieselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily. Biochem. Pharmacol 47:1643-1653.
11. Heyn H, White RB and Stevens JC (1996) Catalytic role of cytochrome P4502B6 in the Af-demethylation of S-mephenytoin. Drug Metabol Dispos 24:948-953.
12. Imaoka S, Yamada T, Hiroi T, Hayashi K, Sakaki T, Yabusaki Y and Funae Y (1998) Multiple forms of human P450 expressed in Saccharomyces cerevisiae. Biochem Pharmacol 51:1041-1050.
13. Jorgensen WL (1991) Rusting of the lock and key model for protein-ligand binding. Science 254:954-955.
14. Kim H, Wang RS, Elovaara E, Raunio H, Pelkonen O, Aoyama T, Vainio H and Nakajima T (1997) Cytochrome P450 isozymes responsible for the metabolism of toluene and styrène ]in human liver microsomes. Xenobiotica 27:657-665.
15. Kirby GM, Wolf CR, Neal GE, Judah DJ, Henderson CJ, Srivatanakul P and Wild CP (1993) In vitro metabolism of Aflatoxin Bj by normal and tumorous liver tissue from Thailand. Carcinogenesis 14:2613-2620.
16. Koley AP, Robinson RC and Friedman FK (1996) Cytochrome P450 conformation and substrate interactions as probed by CO binding kinetics. Biochimie 78:706-713
17. Koley AP, Robinson RC, Markowitz A and Friedman FK (1997) Drug-drug interactions: Effect of quinidine on nifedipine binding to human cytochrome P450 3A4. Biochem Pharmacol 53:455-460.
18. Kronbach T, Mathys D, Umeno M, Gonzalez FJ and Meyer UA (1989) Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4. Mol Pharmaccl 36:89-96.
19. Laemmli UK (1970) Cleavage of structural proteins during assembly of the head cf the bacteriophage T4 Nature 227:680-685.
20. Lake BG (1987) Preparation and characterisation of microsomal fractions for studies on xenobiotic metabolism, in Biochemical Toxicology: A Practical Approach (Snell K and Mullock B eds) pp 183-215, IRL Press, Oxford, England.
21. McLean MA, Yeom H and Sugar SG (1996) Carbon monoxide binding to cytochrome P450BM-3: Evidence for a substrate-dependent conformational change. Biochimie 78:700-705.
22. Nash T (1953) The colorimetric estimation of formaldehyde by means of th Hantzsch reaction. Biochem J 55:416-421.
23. Prough RA and Ziegler DM (1977) The relative participation of liver microsomal
24. aminé oxidase and cytochrome P-450 in JV-demethylation reactions. Arch Biochem Biophys 80:363-373.
25. Rendic S and Di Carlo FJ (1997) Human cytochrome P450 enzymes: A status report summarizing their reactions, substrates, inducers and inhibitors. Drug Metab Rev 29:413-580.
26. Segel IH (1993) Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems, John Wiley and Sons Inc., New York.
27. Shimada T, Yamazaki H, Mimura M, Inui Y and Guengerich FP (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414-423.
28. Sonderfan AJ, Arlotto MP, Dutton DR, McMillen SK and Parkinson A (1987) Regulation of testosterone hydroxylation by rat liver microsomal cytochrome-P450. Arch Biochem Biophys 255:27-41.
29. Strom S, Pisarov LA, Dorko K, Thompson MT, Schuetz JD and Schuetz EG (1996) Use of Human Hepatocytes To Study P450 Gene Induction, Vol. 272. Methods in Enzymology, pp 388-401, Academic Press, New York, NY.
30. Thummel KE, Shen DD, Podoll TD, Kunze KL, Trager WF, Hartwell PS, Raisys VA, Marsh CL, McVicar JP, Barr DM, Perkins JD and Carithers RL (1994) Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-In vivo correlations in liver transplant patients. J Pharmacol Exp Ther 271:549-556.
31. Towbin H, Staehelin T and Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheet; procedure and some applications. Proc Natl Acad Sei USA 76:4350-4354.
32. Ueng Y-F, Kuwabara T, Chun Y-J and Guengerich FP (1997) Cooperativity in oxidations catalyzed by cytochrome P450 3A4. Biochemistry 36:370-381.
33. van der Hoeven TA and Coon M (1974) Preparation and properties of partially purified cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate-cytochrome P450-reductase from rabbit liver microsomes. J Biol Chem 249:6302-6310.
34. Waxman DJ, Lapenson DP, Aoyama T, Gelboin HV, Gonzalez FJ and Korzekwa K (1991) Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s. Arch. Biochem Biophys 290:160-166.
35. Wrighton SA and Stevens JC (1992) The human hepatic cytochromes P450 involved in drug metabolism. Grit Rev Toxicol 22:1-21.
36. Wrighton SA, VandenBranden M, Becker GW, Black SD and Thomas PE (1992) Two monoclonal antibodies recognizing different epitopes on rat cytochrome IIB1 react with human HEI. Mol Pharmacol 41:76-82.
37. Wrighton SA, Vandenbranden M, Stevens JC and Shipley LA (1993) In vitro methods for assessing human hepatic drug metabolism: their use in. Drug Metab Reu 25:453-84.
38. Yamano S, Nhamburo FT, Aoyama T, Meyer UA, Inaba T, Kalow W, Gelboin HV, McBride OW and Gonzalez FJ (1989) cDNA cloning and sequence and cDNAdirected expression of human P450IIB1: Identification of a normal and two variant cDNAs derived from the CYP2B locus on chromosome 19 and differential expression of the IIB mRNAs in human liver. Biochemistry 28:7340-7348.
39. Yamazaki H, Inoue K, Mimura M, Oda Y, Guengerich FP and Shimada T (1996) 7-Ethoxycoumarin 0-deethylation catalyzed by cytochromes P450 1A2 and 2E1 in human liver microsomes. Biochem Pharmacol 51:313-319.
40. Yang TJ, Krausz KW, Shou M, Yang SK, Euters JTM, Gonzalez FJ and Gelboin HV (1998) Inhibitory monoclonal antibody to human cytochrome P450 2B6. Biochem Pharmacol 55:1633-1640.
41. Yang TJ, Shou M, Yang SK, Buters JTM, Krausz KW, Gonzalez FJ and Gelboin HV (1997) Monoclonal antibodies to human cytochrome P450 2B6 (abstract). Toxicologist 39:400.
42. Send reprint requests to: Dr. Steven Wrighton, Department of Drug Disposition, Lilly Research Laboratories, Eli Lilly and Co., Lilly Corporate Center, Drop Code 0825, Indianapolis, IN 46285.